We are live on ! Find out more
ALT icon

Altimmune
ALT

128 hedge funds and large institutions have $1.03B invested in Altimmune in 2022 Q4 according to their latest regulatory filings, with 36 funds opening new positions, 38 increasing their positions, 35 reducing their positions, and 30 closing their positions.

New
Increased
Maintained
Reduced
Closed

719% more call options, than puts

Call options by funds: $60M | Put options by funds: $7.33M

61% more capital invested

Capital invested by funds: $640M → $1.03B (+$391M)

20% more first-time investments, than exits

New positions opened: 36 | Existing positions closed: 30

5% more funds holding

Funds holding: 122 → 128 (+6)

9% more repeat investments, than reductions

Existing positions increased: 38 | Existing positions reduced: 35

0% more funds holding in top 10

Funds holding in top 10: 4 → 4 (0)

7.09% less ownership

Funds ownership: 102.32% → 95.24% (-7.1%)

Holders
128
Holders Change
+6
Holders Change %
+4.92%
% of All Funds
2.06%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
36
Increased
38
Reduced
35
Closed
30
Calls
$60M
Puts
$7.33M
Net Calls
+$52.7M
Net Calls Change
+$22.7M

Top Buyers

1
State Street
State Street
Massachusetts
+$28.3M
2
APM
Avidity Partners Management
Texas
+$14.7M
3
PAMS
Pictet Asset Management (Switzerland)
Switzerland
+$12.1M
4
Citadel Advisors
Citadel Advisors
Florida
+$11.6M
5
Jennison Associates
Jennison Associates
New York
+$8.39M

Top Sellers

1
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$49.5M
2
DCM
Driehaus Capital Management
Illinois
-$15.6M
3
BBA
Baker Bros. Advisors
New York
-$12.5M
4
Balyasny Asset Management
Balyasny Asset Management
Illinois
-$9.64M
5
LGM
Logos Global Management
California
-$9.58M
Name Holding Trade Value Shares
Change 		Change in
Stake
BNP Paribas Financial Markets
51
BNP Paribas Financial Markets
France
$1.73M +$255K +22,746 +28%
Ensign Peak Advisors
52
Ensign Peak Advisors
Utah
$1.55M +$417K +37,115 +65%
DA
53
DCF Advisers
Connecticut
$1.33M -$1.67M -148,320 -65%
Walleye Trading
54
Walleye Trading
New York
$1.29M +$880K +78,324 New
PMAM
55
Picton Mahoney Asset Management
Ontario, Canada
$1.24M +$193K +17,220 +30%
SAM
56
Silvercrest Asset Management
New York
$1.03M – – –
UBS AM
57
UBS AM
Illinois
$900K +$614K +54,700 New
Bank of New York Mellon
58
Bank of New York Mellon
New York
$877K -$222K -19,804 -27%
BFM
59
Boothbay Fund Management
New York
$859K -$389K -34,669 -40%
CM
60
Caption Management
Oklahoma
$857K -$32.5K -2,896 -5%
SCM
61
Silverarc Capital Management
Massachusetts
$831K -$561K -49,923 -50%
State of Wisconsin Investment Board
62
State of Wisconsin Investment Board
Wisconsin
$808K +$552K +49,113 New
AR
63
Advisory Research
Illinois
$727K +$102K +9,066 +26%
California State Teachers Retirement System (CalSTRS)
64
California State Teachers Retirement System (CalSTRS)
California
$701K +$478K +42,584 New
GCP
65
GSA Capital Partners
United Kingdom
$685K -$11.2K -1,000 -2%
Skandinaviska Enskilda Banken (SEB)
66
Skandinaviska Enskilda Banken (SEB)
Sweden
$634K -$25.1K -2,234 -5%
CS
67
Credit Suisse
Switzerland
$627K +$428K +38,137 New
CAM
68
ClariVest Asset Management
California
$615K -$7.86K -700 -2%
T. Rowe Price Associates
69
T. Rowe Price Associates
Maryland
$591K -$1.11M -98,714 -73%
AA
70
ALPS Advisors
Colorado
$548K +$73.5K +6,546 +24%
EFM
71
E Fund Management
China
$515K +$120K +10,646 +52%
TRCT
72
Tower Research Capital (TRC)
New York
$482K +$1.92K +171 +0.6%
LCM
73
Landscape Capital Management
New Jersey
$477K +$325K +28,975 New
D.E. Shaw & Co
74
D.E. Shaw & Co
New York
$456K +$311K +27,702 New
SG Americas Securities
75
SG Americas Securities
New York
$392K +$110K +9,785 +70%
1 2
3
4 5

ALT Hedge Fund Activity: Q4 2022 in Review

128 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Altimmune (ALT) for Q4 2022, worth a combined $1.03B — up 61% from $640M a quarter earlier.

Buyers outnumbered sellers: 36 funds opened new ALT positions and 30 closed out — a net gain of 6 holders — while 38 added to existing stakes and 35 trimmed.

The largest buyer was State Street, adding an estimated $28.3M. The largest seller was Janus Henderson Group, cutting an estimated $49.5M.

  • 128 institutional investors held Altimmune (ALT) as of Q4 2022, up from 122 in Q3 2022.
  • Funds reported $1.03B of Altimmune stock for Q4 2022, up 61% quarter-over-quarter.
  • 36 funds opened new Altimmune positions in Q4 2022 and 30 closed out, a net change of +6 holders.
  • The largest Altimmune buyer in Q4 2022 was State Street, an estimated $28.3M added.
  • The largest Altimmune seller in Q4 2022 was Janus Henderson Group, an estimated $49.5M sold.

Based on aggregated 13F filings for Q4 2022.